search
Back to results

CAD-EYE System for the Detection of Neoplastic Lesions in Patients With Lynch Syndrome (CADLYNCH)

Primary Purpose

Lynch Syndrome

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Colorectal cancer screening with CAD EYE colonoscopy
Sponsored by
PERROD Guillaume
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Lynch Syndrome focused on measuring Lynch Syndrome, CAD EYE, adenoma detection rate, colorectal screening, artificial intelligence

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Confirmed pathogenic mutation (path_MLH1, path_MSH2, path_MSH6, path_PMS2, path_EpCAM) Male or female of legal age at time of colonoscopy prescription. Patient agreeing to participate in the study Person affiliated with or benefiting from a social security scheme Free, informed and express consent Exclusion Criteria: Patient undergoing total colectomy with ileoanal or ileosigmoid anastomosis Patient with a history of Crohn's disease or ulcerative colitis Patients with a known allergy or intolerance to polyethylene glycol and ascorbic acid. Patients unable to undergo fractionated colonic preparation Inadequate colonic preparation: Boston sub-score <2 per segment Patient under guardianship or protected person Patient who does not understand French or cannot read Person not affiliated to a Social Security system. Pregnant women

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    CAD-EYE group: Colorectal cancer screening with CAD EYE colonoscopy

    CE group : Colorectal cancer screening with indigo carmine chromo colonoscopy

    Arm Description

    The colonoscopy procedure for each patient will be no different from a conventional colonoscopy examination. In the CAD EYE group, descent is performed under white light, with the CAD EYE system switched on (device with CE mark). When polyps are detected, they are rigorously described and histological predictions of endoscopist and CAD EYE will be reported separately.

    The colonoscopy procedure for each patient will be no different from a conventional colonoscopy examination. In the CE group, descent is performed under white light with indigo carmin chromoendoscopy (0.4%) applied through a catheter spray. When polyps are detected, they are rigorously described and histological prediction of the endoscopist reported.

    Outcomes

    Primary Outcome Measures

    to evaluate the effectiveness of the CAD EYE system in screening for neoplastic lesions in Lynch syndrome.
    Comparison of the adenoma detection rate (ADR) between the CAD-EYE group and the indigo carmin chromoendoscopy (CE) group (reference technique).

    Secondary Outcome Measures

    Detection rates of specific lesions
    Mean number of adenomas and serrated lesions per patient
    Diagnostic performance of CAD EYE
    Comparison of the diagnostic performance of CAD EYE assessed by specificity, negative predictive value and positive predictive value for the characterization (adenoma/hyperplastic) of colonic polyps with the CAD EYE automated detection system. The anatomopathology of polyps was taken as the diagnostic reference.
    Rate of resect and discard strategy
    Evaluation of the feasibility of a "resect and discard" strategy in Lynch Syndrome. Retrospective analysis comparing CAD-EYE histological prediction vs. endoscopist prediction, using histological report as reference examination (Sensitivity and negative predictive value).
    Time of Colonoscopies
    Comparison of different procedure times between the 2 groups. Total procedure time will be defined as the time from endoscope insertion to extraction through the anus. Withdrawal time will be defined as the time spent on inspection, from the cecum to extraction of the endoscope through the anus, excluding the time required for polypectomy.

    Full Information

    First Posted
    July 10, 2023
    Last Updated
    July 18, 2023
    Sponsor
    PERROD Guillaume
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05963191
    Brief Title
    CAD-EYE System for the Detection of Neoplastic Lesions in Patients With Lynch Syndrome
    Acronym
    CADLYNCH
    Official Title
    Evaluation of the CAD-EYE System for the Detection of Colorectal Neoplastic Lesions in Patients With Lynch Syndrome
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    October 2, 2023 (Anticipated)
    Primary Completion Date
    October 2, 2023 (Anticipated)
    Study Completion Date
    October 2, 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    PERROD Guillaume

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    Lynch syndrome (LS) is the most common genetic predisposition syndrome for colorectal cancer (CRC), responsible for around 2-4% of cancers. It is characterized by a pathogenic germline mutation in one of the DNA mismatch repair genes (path_MMR) MLH1, MSH2, MSH6, PMS2 or a deletion in the 3' region of the Epcam gene. Patients followed up for LS are at high risk of developing CRC at an early age, and have a high cumulative CRC risk. In this context, CRC screening by colonoscopy is of major importance, as it is associated with a reduction in both CRC incidence and mortality. In France, the Institut National du Cancer (INCa) recommends colonoscopy with indigo carmine chromoendoscopy (CE), as it is associated with a significant increase in the adenoma detection rate (ADR) compared with white light. However, EC is not routinely performed in clinical practice, as it is a time-consuming technique requiring a dedicated slot with a trained operator. Recent years have seen the emergence of artificial intelligence techniques for real-time polyp detection aids or CADe devices. These easy-to-use systems have shown very promising results compared with high-definition (HD) white light. Indeed, data from the first meta-analysis of 5 randomized controlled trials (4354 patients) confirmed a significantly higher ADD in the CADe group than in the HD group (36.6% vs. 25.2%; 95% CI], 1.27-1.62; P < 0.01; I2 Z 42%) 10. The CAD EYE system (Fujifilm) is a CADe device supporting both detection (sensitivity > 95%) and characterization of colonic polyps in real time. To date, artificial intelligence has never been evaluated for CRC screening in patients followed up for LS. The aim of this work is to evaluate the effectiveness of the CAD EYE system in this specific population. To this end, we intend to conduct a randomized, controlled, non-inferiority trial comparing CAD EYE with CE in patients with LS.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Lynch Syndrome
    Keywords
    Lynch Syndrome, CAD EYE, adenoma detection rate, colorectal screening, artificial intelligence

    7. Study Design

    Primary Purpose
    Diagnostic
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    272 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    CAD-EYE group: Colorectal cancer screening with CAD EYE colonoscopy
    Arm Type
    Experimental
    Arm Description
    The colonoscopy procedure for each patient will be no different from a conventional colonoscopy examination. In the CAD EYE group, descent is performed under white light, with the CAD EYE system switched on (device with CE mark). When polyps are detected, they are rigorously described and histological predictions of endoscopist and CAD EYE will be reported separately.
    Arm Title
    CE group : Colorectal cancer screening with indigo carmine chromo colonoscopy
    Arm Type
    No Intervention
    Arm Description
    The colonoscopy procedure for each patient will be no different from a conventional colonoscopy examination. In the CE group, descent is performed under white light with indigo carmin chromoendoscopy (0.4%) applied through a catheter spray. When polyps are detected, they are rigorously described and histological prediction of the endoscopist reported.
    Intervention Type
    Device
    Intervention Name(s)
    Colorectal cancer screening with CAD EYE colonoscopy
    Intervention Description
    The colonoscopy procedure for each patient will be no different from a conventional colonoscopy examination. A colonoscopy is considered complete if the endoscope reaches the appendicular orifice or the terminal ileum. In line with recommendations, water lavage (using a lavage pump) and aspiration of food residues will be performed on ascent and/or descent to visualize the entire colonic mucosa. In the CAD EYE group, descent is performed under white light, with the CAD EYE system switched on. When polyps are detected, they are rigorously described and histological predictions of endoscopist and CAD EYE will be reported separately. Then polyps will be removed by polypectomy or mucosectomy. Removed polyps are then sent for anatomopathological analysis.
    Primary Outcome Measure Information:
    Title
    to evaluate the effectiveness of the CAD EYE system in screening for neoplastic lesions in Lynch syndrome.
    Description
    Comparison of the adenoma detection rate (ADR) between the CAD-EYE group and the indigo carmin chromoendoscopy (CE) group (reference technique).
    Time Frame
    Through study completion, an average of 2 years
    Secondary Outcome Measure Information:
    Title
    Detection rates of specific lesions
    Description
    Mean number of adenomas and serrated lesions per patient
    Time Frame
    Through study completion, an average of 2 years
    Title
    Diagnostic performance of CAD EYE
    Description
    Comparison of the diagnostic performance of CAD EYE assessed by specificity, negative predictive value and positive predictive value for the characterization (adenoma/hyperplastic) of colonic polyps with the CAD EYE automated detection system. The anatomopathology of polyps was taken as the diagnostic reference.
    Time Frame
    Through study completion, an average of 2 years
    Title
    Rate of resect and discard strategy
    Description
    Evaluation of the feasibility of a "resect and discard" strategy in Lynch Syndrome. Retrospective analysis comparing CAD-EYE histological prediction vs. endoscopist prediction, using histological report as reference examination (Sensitivity and negative predictive value).
    Time Frame
    Through study completion, an average of 2 years
    Title
    Time of Colonoscopies
    Description
    Comparison of different procedure times between the 2 groups. Total procedure time will be defined as the time from endoscope insertion to extraction through the anus. Withdrawal time will be defined as the time spent on inspection, from the cecum to extraction of the endoscope through the anus, excluding the time required for polypectomy.
    Time Frame
    Through study completion, an average of 2 years

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    90 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Confirmed pathogenic mutation (path_MLH1, path_MSH2, path_MSH6, path_PMS2, path_EpCAM) Male or female of legal age at time of colonoscopy prescription. Patient agreeing to participate in the study Person affiliated with or benefiting from a social security scheme Free, informed and express consent Exclusion Criteria: Patient undergoing total colectomy with ileoanal or ileosigmoid anastomosis Patient with a history of Crohn's disease or ulcerative colitis Patients with a known allergy or intolerance to polyethylene glycol and ascorbic acid. Patients unable to undergo fractionated colonic preparation Inadequate colonic preparation: Boston sub-score <2 per segment Patient under guardianship or protected person Patient who does not understand French or cannot read Person not affiliated to a Social Security system. Pregnant women
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Guillaume Perrod, MD
    Phone
    +33 1 56 09 34 17
    Email
    guillaume.perrod@aphp.fr

    12. IPD Sharing Statement

    Learn more about this trial

    CAD-EYE System for the Detection of Neoplastic Lesions in Patients With Lynch Syndrome

    We'll reach out to this number within 24 hrs